$421 Million is the total value of DAFNA Capital Management LLC's 89 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 39.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $91,933,000 | +32.0% | 13,680,554 | 0.0% | 21.81% | +5.3% | |
| FATE | Sell | FATE THERAPEUTICS INC | $25,919,000 | -14.7% | 314,360 | -6.0% | 6.15% | -32.0% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $20,215,000 | -12.9% | 207,911 | +0.5% | 4.80% | -30.5% |
| DRNA | DICERNA PHARMACEUTICALS INC | $15,029,000 | +16.1% | 587,756 | 0.0% | 3.57% | -7.4% | |
| SAGE | SAGE THERAPEUTICS INC | $13,571,000 | -13.5% | 181,306 | 0.0% | 3.22% | -31.0% | |
| MORF | Buy | MORPHIC HOLDING INC | $11,483,000 | +456.9% | 181,467 | +195.2% | 2.72% | +343.6% |
| NRIX | New | NURIX THERAPEUTICS INC | $9,523,000 | – | 306,320 | +100.0% | 2.26% | – |
| ATRC | Sell | ATRICURE INC | $8,421,000 | +13.5% | 128,529 | -3.5% | 2.00% | -9.5% |
| AFMD | Buy | AFFIMED N V | $7,830,000 | +53.9% | 989,857 | +13.2% | 1.86% | +22.7% |
| IDYA | IDEAYA BIOSCIENCES INC | $7,794,000 | +67.9% | 331,661 | 0.0% | 1.85% | +33.8% | |
| DXCM | DEXCOM INC | $7,597,000 | -2.8% | 21,138 | 0.0% | 1.80% | -22.5% | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $7,277,000 | +36.5% | 406,535 | +17.3% | 1.73% | +8.9% |
| PRQR | Sell | PROQR THERAPEUTICS N V | $7,271,000 | +39.9% | 1,100,000 | -11.1% | 1.72% | +11.6% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $7,163,000 | -19.0% | 73,655 | -20.1% | 1.70% | -35.4% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $6,938,000 | +678.7% | 151,231 | +572.1% | 1.65% | +521.1% |
| BHVN | Buy | BIOHAVEN PHARMACEUTICALS HOLD | $6,398,000 | -9.1% | 93,600 | +14.0% | 1.52% | -27.5% |
| IBB | Sell | ISHARES TR NASDAQ BIOTECHetf | $6,083,000 | -15.3% | 40,400 | -14.8% | 1.44% | -32.5% |
| GLPG | Sell | GALAPAGOS NVspon adr | $5,795,000 | -27.2% | 75,175 | -6.5% | 1.38% | -41.9% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $5,771,000 | +240.9% | 48,000 | +188.0% | 1.37% | +171.6% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $5,739,000 | -13.3% | 149,700 | -1.0% | 1.36% | -30.8% |
| CARA | CARA THERAPEUTICS INC | $5,676,000 | +43.5% | 261,442 | 0.0% | 1.35% | +14.4% | |
| PLX | New | PROTALIX BIOTHERAPEUTICS INC | $5,374,000 | – | 1,204,825 | +100.0% | 1.28% | – |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $5,323,000 | -9.8% | 76,715 | -0.1% | 1.26% | -28.1% |
| ACET | Buy | ADICET BIO INC | $5,037,000 | +362.1% | 385,077 | +396.4% | 1.20% | +268.8% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $4,929,000 | +26.5% | 275,840 | -4.4% | 1.17% | +0.8% |
| LMNX | LUMINEX CORP | $4,916,000 | +38.0% | 154,091 | 0.0% | 1.17% | +10.0% | |
| ARAY | Sell | ACCURAY INC | $4,662,000 | +14.7% | 941,800 | -3.3% | 1.11% | -8.5% |
| HOOK | Buy | HOOKIPA PHARMA INC | $4,619,000 | +66.6% | 343,455 | +37.4% | 1.10% | +32.8% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $4,211,000 | +76.0% | 1,249,648 | +87.0% | 1.00% | +40.3% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,738,000 | +4.2% | 4,000,000 | 0.0% | 0.89% | -16.9% | ||
| TBIO | TRANSLATE BIO INC | $3,717,000 | -10.5% | 225,393 | 0.0% | 0.88% | -28.6% | |
| RDHL | New | REDHILL BIOPHARMA LTDsponsored ads | $3,337,000 | – | 455,933 | +100.0% | 0.79% | – |
| MRUS | New | MERUS N V | $3,297,000 | – | 157,841 | +100.0% | 0.78% | – |
| STIM | Sell | NEURONETICS INC | $3,138,000 | -36.3% | 253,717 | -42.8% | 0.74% | -49.2% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $2,995,000 | -22.7% | 23,237 | 0.0% | 0.71% | -38.3% | |
| FSII | New | FS DEVELOPMENT CORP II | $2,988,000 | – | 300,000 | +100.0% | 0.71% | – |
| VERO | Sell | VENUS CONCEPT INC | $2,891,000 | +11.4% | 1,230,400 | -18.0% | 0.69% | -11.1% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $2,830,000 | +10.2% | 447,400 | -1.9% | 0.67% | -12.2% |
| HARP | Buy | HARPOON THERAPEUTICS INC | $2,650,000 | +87.4% | 126,663 | +48.8% | 0.63% | +49.4% |
| ALEC | ALECTOR INC | $2,568,000 | +33.1% | 127,500 | 0.0% | 0.61% | +6.1% | |
| ETNB | 89BIO INC | $2,498,000 | -2.8% | 105,478 | 0.0% | 0.59% | -22.5% | |
| NTUS | Buy | NATUS MEDICAL INC | $2,450,000 | +42.9% | 95,653 | +11.8% | 0.58% | +13.9% |
| IFRX | New | INFLARX NV | $2,340,000 | – | 600,000 | +100.0% | 0.56% | – |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $2,270,000 | – | 677,500 | +100.0% | 0.54% | – |
| MEIP | Sell | MEI PHARMA INC | $2,216,000 | +21.5% | 646,000 | -6.5% | 0.53% | -3.1% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $2,181,000 | -41.0% | 430,111 | -52.4% | 0.52% | -53.0% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,141,000 | – | 83,000 | +100.0% | 0.51% | – |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $2,087,000 | +93.8% | 603,042 | +88.1% | 0.50% | +54.7% |
| GMTX | New | GEMINI THERAPEUTICS INC | $2,033,000 | – | 150,000 | +100.0% | 0.48% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $2,011,000 | +53.4% | 124,263 | +152.2% | 0.48% | +22.3% |
| COGT | New | COGENT BIOSCIENCES INC | $1,963,000 | – | 223,554 | +100.0% | 0.47% | – |
| STRO | SUTRO BIOPHARMA INC | $1,935,000 | +4.9% | 85,000 | 0.0% | 0.46% | -16.4% | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $1,928,000 | -23.2% | 44,926 | +2.3% | 0.46% | -38.8% |
| BWAY | New | BRAINWAY LTDsponsored ads | $1,806,000 | – | 200,000 | +100.0% | 0.43% | – |
| ATHA | Buy | ATHIRA PHARMA INC | $1,684,000 | +197.5% | 91,531 | +453.7% | 0.40% | +138.1% |
| KNTE | Sell | KINNATE BIOPHARMA INC | $1,649,000 | -39.2% | 52,915 | -22.3% | 0.39% | -51.5% |
| CGEN | Buy | COMPUGEN LTDord | $1,624,000 | +16.4% | 189,002 | +64.1% | 0.38% | -7.2% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $1,617,000 | +25.5% | 57,600 | +16.1% | 0.38% | +0.3% |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,556,000 | +13.1% | 1,500,000 | 0.0% | 0.37% | -9.8% | ||
| LQDA | LIQUIDIA TECHNOLOGIES INC | $1,547,000 | -8.8% | 575,000 | 0.0% | 0.37% | -27.3% | |
| JNJ | JOHNSON AND JOHNSON | $1,545,000 | +4.5% | 9,400 | 0.0% | 0.37% | -16.6% | |
| KDMN | Sell | KADMON HOLDINGS INC | $1,535,000 | -21.4% | 394,561 | -16.1% | 0.36% | -37.3% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $1,533,000 | – | 337,770 | +100.0% | 0.36% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $1,505,000 | – | 58,600 | +100.0% | 0.36% | – |
| INFI | New | INFINITY PHARMACEUTICALS INC | $1,483,000 | – | 459,260 | +100.0% | 0.35% | – |
| KURA | Buy | KURA ONCOLOGY INC | $1,464,000 | +398.0% | 51,800 | +475.6% | 0.35% | +298.9% |
| CFMS | New | CONFORMIS INC | $1,287,000 | – | 1,300,000 | +100.0% | 0.30% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $1,286,000 | +479.3% | 57,500 | +475.0% | 0.30% | +362.1% |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $1,201,000 | -15.8% | 113,302 | +0.1% | 0.28% | -32.8% |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $1,190,000 | +14.8% | 81,432 | +68.2% | 0.28% | -8.7% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $994,000 | – | 10,509 | +100.0% | 0.24% | – |
| OTIC | OTONOMY INC | $993,000 | -60.6% | 389,592 | 0.0% | 0.24% | -68.5% | |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $942,000 | – | 275,500 | +100.0% | 0.22% | – |
| GNFT | Buy | GENFIT S Aads | $871,000 | +58.7% | 188,549 | +64.9% | 0.21% | +27.0% |
| TBPH | New | THERAVANCE BIOPHARMA INC | $840,000 | – | 41,165 | +100.0% | 0.20% | – |
| INGN | INOGEN INC | $788,000 | +17.6% | 15,000 | 0.0% | 0.19% | -6.0% | |
| SCYX | Sell | SCYNEXIS INC | $714,000 | -53.3% | 89,874 | -55.1% | 0.17% | -62.9% |
| MASI | MASIMO CORPORATION | $689,000 | -14.4% | 3,000 | 0.0% | 0.16% | -32.1% | |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $655,000 | -10.8% | 5,600 | -15.2% | 0.16% | -28.9% |
| NXTC | NEXTCURE INC | $651,000 | -8.2% | 65,000 | 0.0% | 0.15% | -27.0% | |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $644,000 | – | 197,500 | +100.0% | 0.15% | – |
| XFOR | New | X4 PHARMACEUTICALS INC | $602,000 | – | 69,912 | +100.0% | 0.14% | – |
| ISEE | Buy | IVERIC BIO INC | $556,000 | +16.8% | 89,951 | +30.5% | 0.13% | -7.0% |
| RDUS | Sell | RADIUS HEALTH INC | $302,000 | -23.2% | 14,500 | -34.1% | 0.07% | -38.5% |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $291,000 | – | 10,000 | +100.0% | 0.07% | – |
| SCPH | SCPHARMACEUTICALS INC | $259,000 | +25.7% | 38,891 | 0.0% | 0.06% | 0.0% | |
| LCTX | Sell | LINEAGE CELL THERAPEUTICS INC | $177,000 | +25.5% | 75,400 | -5.8% | 0.04% | 0.0% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $153,000 | -86.5% | 18,337 | -88.6% | 0.04% | -89.3% |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $148,000 | – | 8,000 | +100.0% | 0.04% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -5,200 | -100.0% | -0.11% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -58,222 | -100.0% | -0.26% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -30,273 | -100.0% | -0.39% | – |
| FSDC | Exit | FS DEVELOPMENT CORP | $0 | – | -150,000 | -100.0% | -0.49% | – |
| PRVL | Exit | PREVAIL THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.52% | – |
| CNST | Exit | CONSTELLATION PHARMACEUTICAL | $0 | – | -100,594 | -100.0% | -0.86% | – |
| SAVA | Exit | CASSAVA SCIENCES INC | $0 | – | -450,000 | -100.0% | -0.91% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.